These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1381611)
1. Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects. Mori T; Handa K; Terao Y; Tanaka H; Kiyonaga A; Shindo M; Matsunaga A; Sasaki J; Arakawa K Cardiovasc Drugs Ther; 1992 Aug; 6(4):387-90. PubMed ID: 1381611 [TBL] [Abstract][Full Text] [Related]
2. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects. Berlin I; Lechat P; Deray G; Landault C; Maistre G; Chermat V; Brouard R; Ressayre C; Puech AJ Eur J Clin Pharmacol; 1993; 44(2):127-33. PubMed ID: 8095894 [TBL] [Abstract][Full Text] [Related]
3. Effect of arotinolol on hemodynamics and plasma atrial natriuretic peptide at rest and during stress in spontaneously hypertensive rats. Yamamoto J; Matsubara H; Nakai M Clin Exp Hypertens A; 1989; 11(8):1441-54. PubMed ID: 2482144 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol. McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612 [TBL] [Abstract][Full Text] [Related]
6. Plasma atrial natriuretic peptide during brief upright and supine exercise in humans. Perrault H; Cantin M; Thibault G; Brisson GR; Brisson G; Beland M J Appl Physiol (1985); 1989 May; 66(5):2159-67. PubMed ID: 2526114 [TBL] [Abstract][Full Text] [Related]
7. Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol. Nakashima M; Uematsu T; Takiguchi Y; Hashimoto H; Watanabe I; Morioka S; Hibino T Eur J Clin Pharmacol; 1985; 28(4):391-6. PubMed ID: 2411566 [TBL] [Abstract][Full Text] [Related]
8. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension. Predel HG; Mainka W; Schillings W; Knigge H; Montiel J; Fallois J; Agrawal R; Schramm T; Graf C; Giannetti BM; Bjarnason-Wehrens B; Prinz U; Rost RE J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802 [TBL] [Abstract][Full Text] [Related]
9. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise. Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473 [TBL] [Abstract][Full Text] [Related]
10. Responses of catecholamines, renin-angiotensin system, and atrial natriuretic peptide to exercise in untrained men and women. Kinugawa T; Ogino K; Miyakoda H; Saitoh M; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C; Sato R Gen Pharmacol; 1997 Feb; 28(2):225-8. PubMed ID: 9013199 [TBL] [Abstract][Full Text] [Related]
11. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction. Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109 [TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise. Omvik P; Lund-Johansen P; Myking O J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157 [TBL] [Abstract][Full Text] [Related]
13. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676 [TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935 [TBL] [Abstract][Full Text] [Related]
15. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension. Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844 [TBL] [Abstract][Full Text] [Related]
16. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354 [TBL] [Abstract][Full Text] [Related]
17. Effects of ketanserin on cardiovascular, sympatho-adrenal and endocrine systems during physical exercise in man. Defer G; Guezennec CY; Fraitag B; Lhoste F Fundam Clin Pharmacol; 1987; 1(2):135-43. PubMed ID: 3315914 [TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise. Hespel P; Lijnen P; Vanhees L; Fagard R; Amery A J Appl Physiol (1985); 1986 Jan; 60(1):108-13. PubMed ID: 3003020 [TBL] [Abstract][Full Text] [Related]
19. Perceived exertion and gas exchange after calcium and beta-blockade in atrial fibrillation. Myers J; Atwood JE; Sullivan M; Forbes S; Friis R; Pewen W; Froelicher V J Appl Physiol (1985); 1987 Jul; 63(1):97-104. PubMed ID: 2887542 [TBL] [Abstract][Full Text] [Related]
20. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline. Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]